The new medical domain represents hybrid sequences. Such synthetic entities combine segments of multiple peptide sources, enabling for unique therapeutic properties. This method provides a exciting avenue to create https://chimera-peptides394600.blogdemls.com/43235088/chimera-peptides-a-novel-therapeutic-frontier